loading
Schlusskurs vom Vortag:
$4.43
Offen:
$4.42
24-Stunden-Volumen:
43,860
Relative Volume:
0.02
Marktkapitalisierung:
$6.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.20%
1M Leistung:
-15.00%
6M Leistung:
+315.81%
1J Leistung:
+121.35%
1-Tages-Spanne:
Value
$4.15
$4.49
1-Wochen-Bereich:
Value
$3.7801
$4.5677
52-Wochen-Spanne:
Value
$0.9693
$5.84

Entero Therapeutics Inc Stock (ENTO) Company Profile

Name
Firmenname
Entero Therapeutics Inc
Name
Telefon
561-589-7020
Name
Adresse
777 YAMATO ROAD, BOCA RATON
Name
Mitarbeiter
2
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
ENTO's Discussions on Twitter

Vergleichen Sie ENTO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ENTO
Entero Therapeutics Inc
4.25 9.40M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M -52.09M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Entero Therapeutics Inc Aktie (ENTO) Neueste Nachrichten

pulisher
12:09 PM

Institutional scanner results for Entero Therapeutics Inc.2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com

12:09 PM
pulisher
Nov 01, 2025

Will Entero Therapeutics Inc. stock recover after recent dropBond Market & AI Powered Market Trend Analysis - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Short interest data insights for Entero Therapeutics Inc.Weekly Stock Summary & Smart Money Movement Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Entero Regains Nasdaq Compliance With Grid AI Acquisition - Florida Today

Nov 01, 2025
pulisher
Oct 31, 2025

Entero Therapeutics Regains Nasdaq Compliance After Extension - TipRanks

Oct 31, 2025
pulisher
Oct 31, 2025

Entero Therapeutics Regains Nasdaq Compliance - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Nasdaq confirms ENTO equity-rule compliance; next filing crucial - Stock Titan

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 04:45:42 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why analysts remain bullish on Entero Therapeutics Inc. stockSwing Trade & Advanced Technical Analysis Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using economic indicators to assess Entero Therapeutics Inc. potentialJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 00:01:01 - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Grid AI Corp. completed the acquisition of Entero Therapeutics, Inc. in a reverse merger transaction. - MarketScreener

Oct 30, 2025
pulisher
Oct 30, 2025

Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO) - ACCESS Newswire

Oct 30, 2025
pulisher
Oct 30, 2025

Entero (NASDAQ: ENTO) acquires GRID AI, adds $50M+ grid tech and Nasdaq compliance - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Entero Therapeutics (NASDAQ: ENTO) acquires 100% of Grid AI, regains Nasdaq compliance - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Entero Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Review & Weekly Stock Performance Updates - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Using data filters to optimize entry into Entero Therapeutics Inc.July 2025 Macro Moves & Safe Capital Growth Stock Tips - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why Entero Therapeutics Inc. stock remains a top recommendationJuly 2025 Short Interest & Risk Controlled Swing Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 01:24:51 - fcp.pa.gov.br

Oct 29, 2025
pulisher
Oct 28, 2025

Why Entero Therapeutics Inc. stock is favored by top institutionsJuly 2025 Chart Watch & Advanced Technical Signal Analysis - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Comparing Entero Therapeutics Inc. in custom built stock radarsMarket Rally & Consistent Growth Equity Picks - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will Entero Therapeutics Inc. stock maintain dividend yieldJuly 2025 Update & Consistent Profit Trade Alerts - fcp.pa.gov.br

Oct 27, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 20:47:42 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 15:21:24 - newser.com

Oct 26, 2025

Finanzdaten der Entero Therapeutics Inc-Aktie (ENTO)

Es liegen keine Finanzdaten für Entero Therapeutics Inc (ENTO) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Kapitalisierung:     |  Volumen (24h):